Free Trial

Clarivate Q1 2024 Earnings Report

Clarivate logo
$4.98 +0.08 (+1.63%)
(As of 12/20/2024 05:31 PM ET)

Clarivate EPS Results

Actual EPS
$0.12
Consensus EPS
$0.10
Beat/Miss
Beat by +$0.02
One Year Ago EPS
N/A

Clarivate Revenue Results

Actual Revenue
$621.20 million
Expected Revenue
$614.57 million
Beat/Miss
Beat by +$6.63 million
YoY Revenue Growth
N/A

Clarivate Announcement Details

Quarter
Q1 2024
Time
N/A

Conference Call Resources

Conference Call Audio

Slide Deck

Did You See Trump’s Bombshell Exec. Order 001? (Ad)

Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office...

I put all the details together for you here — but please hurry. 

Clarivate Earnings Headlines

Clarivate (NYSE:CLVT) to Buyback $500.00 million in Shares
Did You See Trump’s Bombshell Exec. Order 001?
Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office...
Morgan Stanley Remains a Hold on Clarivate (CLVT)
See More Clarivate Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Clarivate? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Clarivate and other key companies, straight to your email.

About Clarivate

Clarivate (NYSE:CLVT) operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications. It also provides Patent and Trademark Renewals, that supports paralegal and admin tasks throughout the patent and trademark protection and maintenance process; CompuMark and Derwent, that supports critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle; IPFolio and Foundation IP that creates a structured environment for the protection and management of global patent and trademark assets. In addition, the company offers Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, that supports the development of new drugs and medical devices from discovery to clinical trials; Cortellis Regulatory Intelligence and OFF-X to monitor drug safety issues and adhere to regulatory protocols; Real World Data and Optimize that inform commercial launch strategy and set pricing for optimal reimbursement. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.

View Clarivate Profile

More Earnings Resources from MarketBeat

Upcoming Earnings